Explore more publications!

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on December 18, 2025

GeeFi's (GEE) Presale Makes News as $1.4M Are Raised Amid Major Market Chaos
JessC, ganadora del InterContinental Music Awards 2025, pone su mirada en Sudamérica
The Mexican Caribbean Tourism Board Shares 2026 Destination Developments and Anticipated Events Following a Dynamic 2025
Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement
GeeFi (GEE) Eyes Phase3's Start as Only 1M Tokens Remain in Current Phase
Adriana’s Insurance Announces Southern California’s Only Free Holiday Ice Skating Event & Santa Tour
Cabo Platinum Announces New Luxury Villa Listing in Puerto Los Cabos
NeuExcell Therapeutics Reports Encouraging Clinical Results with World’s First In Situ Conversion Therapy for Malignant Glioma
CoinLander Attracts Web2 and Web3 Investors Seeking Refuge From Stock Market Uncertainty and Crypto Volatility
Nasdaq-Listed Blue Gold Limited (BGL) Announces Updated Analyst Price Target of Up to $22
GeeFi (GEE) Reports Phase 2 is Nearing Sellout, Reporting Only 5% of Tokens Remaining
BiggerZ.com Powers Nate Diaz’s Viral $20,000 Bet in Jake Paul vs Anthony Joshua Fight
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
Biofrontera Inc. Completes Transfer of Ameluz® and RhodoLED® FDA approval and Associated Intellectual Property Portfolio
Biodexa Announces Pricing of $10 Million Public Offering
Aprea Therapeutics CEO Issues Letter to Shareholders Highlighting Pipeline Progress in 2025 and Outlook for 2026
Latin Metals Provides Spin-Out Transaction Update and Files Technical Report for Para Project
Refined Energy Corp. Approves Dufferin Project Drill Program
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions